CBUS — Cibus, Inc.
—
Nasdaq ·
Materials ·
Chemicals ·
CIK 1705843 ·
Last close
$1.29
Market Cap
$98.47M
52W High
$3.50
52W Low
$1.17
ADV30
264,360
Next earnings
2026-08-13
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 1,681,000 | — | -12,120,000 | -21,222,000 | 324,202,000 | 30,325,000 | 288,722,000 |
| Dec 2025 | 1,057,000 | — | -13,459,000 | -31,286,000 | 305,047,000 | 9,923,000 | 283,218,000 |
| Sep 2025 | 615,000 | — | -15,438,000 | -23,541,000 | 330,226,000 | 23,886,000 | 278,197,000 |
| Jun 2025 | 933,000 | — | -17,946,000 | -25,372,000 | 346,198,000 | 36,463,000 | 271,722,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-50,250,000
Investing CF
$-359,000
Financing CF
$57,343,000
CapEx
$-402,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.97
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-879,473,000
Inventory
—
Receivables
$1,703,000
ST Investments
—
EBIT TTM
$-67,772,000
Pretax Income TTM
$-103,997,000
Interest Exp TTM
$36,225,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,639,000
EBITDA
$-61,541,000
Free Cash Flow
$-51,790,624
Enterprise Value
$348,688,928
Total Cash
$9,923,000
Total Debt
$267,964,992
Shares Out
76,331,634
Trailing EPS
$-1.77
Book Value
$0.40
ROE
-221.0%
ROA
-12.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,639,000 | -67,464,000 | -127,085,000 | 305,047,000 | 283,218,000 | — | -50,591,000 |
| Dec 2024 | 4,262,000 | -76,964,000 | -251,388,000 | 350,069,000 | 252,238,000 | — | -58,043,000 |
| Dec 2023 | 1,817,000 | -69,464,000 | -267,627,000 | 544,411,000 | 206,117,000 | — | -46,210,000 |
| Dec 2022 | 157,000 | -22,370,000 | -16,891,000 | 22,421,000 | 15,188,000 | — | -19,364,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$838,000
NetIncome TTM
$-24,883,000
OpCashFlow TTM
$0
Assets (Latest)
$350,069,000
Forward EPS
$-0.63
Max Pain — expiry 2026-09-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $1.29 · call volume: 3 · put volume: 30
Expected Move to 2026-09-18:
±$1.61
(124.81%) —
implied range
$-0.32 –
$2.90
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| FTLF | FITLIFE BRANDS, INC. | $99.64M | $10.61 | — |
| AAWH | Ascend Wellness Holdings, Inc. | $106.52M | $0.52 | — |
| SLSN | SOLESENCE, INC. | $90.41M | $1.28 | — |
| JUSHF | Jushi Holdings Inc. | $89.86M | $0.45 | — |
| ARQ | Arq, Inc. | $117.19M | $2.73 | — |
News headlines (Yahoo Finance, 1h cache)
Europe Recognizes Nature-Based Plant Improvement, Opening a New Pathway for Cibus
2026-06-17 12:05 · Yahoo
Cibus Names Agricultural Biotechnology Leader Craig Wichner as Chief Executive Officer to Accelerate Growth and Value Creation
2026-06-08 22:30 · Yahoo
Cibus, Inc. Q1 2026 Earnings Call Summary
2026-05-15 12:30 · Yahoo
Cibus Inc (CBUS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Financial Challenges
2026-05-15 05:02 · Yahoo
Cibus Q1 Earnings Call Highlights
2026-05-14 22:10 · Yahoo
Cibus (CBUS) Reports Q1 Loss, Beats Revenue Estimates
2026-05-14 21:50 · Yahoo
Cibus Reports First Quarter Financial Results and Provides Business Update
2026-05-14 20:05 · Yahoo
Bioceres Crop (BIOX) Reports Q3 Loss, Misses Revenue Estimates
2026-05-12 00:05 · Yahoo
Cibus (CBUS) Upgraded to Buy: What Does It Mean for the Stock?
2026-05-06 16:00 · Yahoo
Cibus Announces Transfer of Gene-Edited Herbicide Tolerance Traits in Interoc Rice Seeds for Testing and Production
2026-05-04 11:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.